WELLS FARGO & COMPANY/MN - GLOBUS MED INC ownership

GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 386 filers reported holding GLOBUS MED INC in Q1 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of GLOBUS MED INC
ValueSharesWeighting
Q3 2023$11,953,849
-8.3%
240,762
+10.0%
0.00%0.0%
Q2 2023$13,031,361
+60.2%
218,867
+52.4%
0.00%
+100.0%
Q1 2023$8,131,985
-90.8%
143,573
-87.9%
0.00%
-92.6%
Q4 2022$88,424,822
+60.6%
1,190,586
+28.8%
0.03%
+50.0%
Q3 2022$55,044,000
-8.4%
924,030
-13.7%
0.02%
-5.3%
Q2 2022$60,097,000
+33.9%
1,070,469
+76.0%
0.02%
+58.3%
Q1 2022$44,876,000
+19.4%
608,235
+16.9%
0.01%
+33.3%
Q4 2021$37,576,000
-17.5%
520,432
-12.4%
0.01%
-10.0%
Q3 2021$45,537,000
+13.2%
594,332
+14.5%
0.01%
+11.1%
Q2 2021$40,226,000
+17.7%
518,848
-6.4%
0.01%
+12.5%
Q1 2021$34,177,000
-5.3%
554,201
+0.1%
0.01%
-11.1%
Q4 2020$36,103,000
+43.5%
553,549
+9.0%
0.01%
+28.6%
Q3 2020$25,156,000
-6.4%
507,983
-9.8%
0.01%
-12.5%
Q2 2020$26,880,000
+18.4%
563,437
+5.5%
0.01%0.0%
Q1 2020$22,710,000
-17.9%
533,965
+13.6%
0.01%
+14.3%
Q4 2019$27,675,000
+12.5%
470,028
-2.3%
0.01%0.0%
Q3 2019$24,606,000
-19.5%
481,329
-33.4%
0.01%
-22.2%
Q2 2019$30,570,000
+23.2%
722,717
+43.9%
0.01%
+28.6%
Q1 2019$24,813,000
+10.3%
502,202
-3.3%
0.01%0.0%
Q4 2018$22,486,000
-30.1%
519,554
-8.4%
0.01%
-22.2%
Q3 2018$32,191,000
+28.8%
567,148
+1.2%
0.01%
+28.6%
Q2 2018$25,001,000
-15.1%
560,287
-5.2%
0.01%
-22.2%
Q1 2018$29,432,000
+5.9%
590,778
-12.6%
0.01%
+12.5%
Q4 2017$27,793,000
+42.9%
676,224
+3.4%
0.01%
+33.3%
Q3 2017$19,444,000
+1.8%
654,213
+13.5%
0.01%0.0%
Q2 2017$19,107,000
+10.8%
576,394
-1.0%
0.01%0.0%
Q1 2017$17,245,000
+16.5%
582,190
-2.4%
0.01%
+20.0%
Q4 2016$14,805,000
+38.9%
596,732
+26.4%
0.01%
+25.0%
Q3 2016$10,656,000
+51.3%
472,141
+59.7%
0.00%
+33.3%
Q2 2016$7,044,000
-13.6%
295,588
-13.9%
0.00%0.0%
Q1 2016$8,150,000
-20.1%
343,168
-6.4%
0.00%
-25.0%
Q4 2015$10,202,000
+39.4%
366,738
+3.5%
0.00%
+33.3%
Q3 2015$7,317,000
-18.0%
354,201
+2.0%
0.00%0.0%
Q2 2015$8,918,000
-43.4%
347,395
-44.4%
0.00%0.0%
Q1 2015$15,762,000
+107.3%
624,496
+95.2%
0.00%0.0%
Q4 2014$7,604,000
+33.6%
319,889
+10.6%
0.00%
+50.0%
Q3 2014$5,690,000
+18.3%
289,242
+43.8%
0.00%0.0%
Q2 2014$4,811,000
-43.9%
201,154
-37.7%
0.00%
-50.0%
Q1 2014$8,579,000
+26.8%
322,674
-3.8%
0.00%
+33.3%
Q4 2013$6,768,000
+19.5%
335,361
+3.4%
0.00%0.0%
Q3 2013$5,664,000
+133.6%
324,478
+125.7%
0.00%
+200.0%
Q2 2013$2,425,000143,7910.00%
Other shareholders
GLOBUS MED INC shareholders Q1 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 908,953$59,282,0005.54%
Sterling Investment Advisors, Ltd. 234,623$15,302,0005.20%
Next Capital Management LLC 111,098$7,246,0005.10%
Godshalk Welsh Capital Management, Inc. 77,085$5,027,0003.71%
Pembroke Management, LTD 613,931$40,041,0003.36%
XXEC, Inc. 52,800$3,444,0002.71%
Global Alpha Capital Management Ltd. 302,377$19,721,0002.42%
Van Berkom & Associates Inc. 1,572,303$102,546,0002.35%
PARADIGM CAPITAL MANAGEMENT INC/NY 581,700$37,939,0002.27%
RTW INVESTMENTS, LP 1,640,859$107,017,0001.80%
View complete list of GLOBUS MED INC shareholders